Market Report Source

Overview

Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market.

Kalorama’s Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a solid look at opportunities available for pharmaceutical companies in these emerging markets, including the following information:

• Competitive Activity
• Current Market Size
• Forecast to 2012
• Population, Economy and Demographics
• Health Indicators for each Country
• Market Trends
• Company Profiles

What economic and demographic factors are driving companies to this market? Who are the major players having success in this area? What should companies know about each country’s healthcare system in order to plan their strategy. For each country, this report answers these questions and analyzes markets a look at the following specific segments

• Cardiovascular Drugs
• Gastrointestinal Drugs
• Infection control Drugs
• Neurotherapeutics/CNS Drugs
• Oncology Drugs
• Respiratory Drugs
• Others

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel.

These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY
Overview
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting the Market
Leading Competitors

CHAPTER TWO: INTRODUCTION
Overview
Intellectual Property Rights and Compulsory Licensing
Biosimilar Production
Ethical Issues Regarding DTC Advertising in Developing Regions
World Health
Tobacco Use
Obesity
World Economic Trends
Purchasing Power Trends

CHAPTER THREE: PHARMACEUTICAL MARKETS IN INDIA
Overview and Summary
Regulatory Environment
Economic Development
Healthcare Trends in India
Healthcare Professionals
Demographics
Birth Rates
Life Expectancy
Mortality
Leading Causes of Death
Key Product Segments and Market Indicators
Cardiovascular Drugs
Gastrointestinal Drugs
Infection Control Drugs
Neurotherapuetics and Central Nervous System Drugs
Oncology Drugs
Respiratory Drugs
Other Drugs
Market Analysis
Product Segment Market Analysis
Competitive Outlook and Distribution

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN CHINA
Overview and Summary
Regulatory Environment
Economic Development
Healthcare Trends in China
Healthcare Professionals
Demographics
Birth Rates
Life Expectancy
Mortality
Leading Causes of Death
Key Product Segments and Market Indicators
Cardiovascular Drugs
Gastrointestinal Drugs
Infection Control Drugs
Neurotherapuetics and Central Nervous System Drugs
Oncology Drugs
Respiratory Drugs
Other Drugs
Market Analysis
Product Segment Market Analysis
Competitor Outlook and Distribution

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN RUSSIA
Overview and Summary
Regulatory Environment
Economic Development
Healthcare Trends in Russia
Healthcare Professionals
Demographics
Birth Rates
Life Expectancy
Mortality
Leading Causes of Death
Key Product Segments and Market Indicators
Cardiovascular Drugs
Gastrointestinal Drugs
Infection Control Drugs
Neurotherapuetics and Central Nervous System Drugs
Oncology Drugs
Respiratory Drugs
Other Drugs
Market Analysis
Product Segment Market Analysis
Competitive Outlook and Distribution

CHAPTER SIX: PHARMACEUTICAL MARKETS IN BRAZIL
Overview and Summary
Regulatory Environment
Economic Development
Healthcare Trends in Brazil
Healthcare Professionals
Demographics
Birth Rates
Life Expectancy
Mortality
Leading Causes of Death
Key Product Segments and Market Indicators
Cardiovascular Drugs
Gastrointestinal Drugs
Infection Control Drugs
Neurotherapuetics and Central Nervous System Drugs
Oncology Drugs
Respiratory Drugs
Other Drugs
Market Analysis
Product Segment Market Analysis
Competitive Outlook and Distribution

CHAPTER SEVEN: MARKET SUMMARY
Overview
Markets by Country

CHAPTER EIGHT: GLOBAL LEADERS
Overview
AstraZeneca
GlaxoSmithKline
Novartis AG
Pfizer, Inc.
Roche
Sanofi-Aventis

APPENDIX: LIST OF MAJOR COMPANIES LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY
Figure 1-1: BRIC Market Analysis: 2005-2012

CHAPTER TWO: INTRODUCTION
Table 2-1: Percent of Smokers by Country, Adult Population 15+
Table 2-2: Percent of Population that is Obese*, Estimated 2005
Table 2-3: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
Figure 2-1: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
Table 2-4: Gross National Income Comparison by Country 2000-2005
Figure 2-2: Gross National Income Growth by Country 2000-2005

CHAPTER THREE: PHARMACEUTICAL MARKETS IN INDIA
Table 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Figure 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Table 3-2: India’s Economic Profile
Table 3-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
Table 3-4: Healthcare Professionals in India by Type, Estimated 2004 and 2007
Figure 3-2: Healthcare Professionals in India by Type, Estimated 2004 and 2007
Table 3-5: India – Midyear Population, by Age and Sex, 2007 and 2012
Figure 3-3: India – Midyear Population, by Age, 2007 and 2012
Table 3-6: India Fertility Rates and Births Estimated 2005, 2007; Projected 2008, 2025
Figure 3-4: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025
Table 3-7: India Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
Figure 3-5: India Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025
Table 3-8: India Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
Figure 3-6: India Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
Table 3-9: India Leading Causes of Death, Estimated 2007
Figure 3-7: India Leading Causes of Death, Estimated 2007
Table 3-10: HIV Indicators, India
Figure 3-8: HIV Indicators, India
Table 3-11: Tuberculosis Surveillance and Epidemiology, India
Figure 3-9: Tuberculosis Surveillance and Epidemiology, India
Table 3-12: India Malaria Data, 1990-2003
Figure 3-10: India Malaria Data, 1990-2003
Table 3-13: Cancer Surveillance and Epidemiology, India
Table 3-14: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World
Figure 3-12: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World, 2007
Table 3-15: India Pharmaceutical Market Analysis, 2005-2007
Table 3-16: Forecasted India Pharmaceutical Market Analysis: 2008-2012
Figure 3-13: India Pharmaceutical Market Analysis: 2005-2012
Table 3-17: India Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
Figure 3-14: India Pharmaceutical Market Analysis by Product Segment, 2007
Figure 3-15: India Pharmaceutical Market Forecast by Product Segment, 2012
Table 3-18: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007
Figure 3-16: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN CHINA
Table 4-1: China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Figure 4-1: China Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Table 4-2: Chinese and U.S. Drug Review Timeline
Table 4-3: China’s Economic Profile
Table 4-4: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
Table 4-5: Healthcare Professionals in China by Type, Estimated 2004 and 2007
Figure 4-2: Healthcare Professionals in China by Type, Estimated 2004
Table 4-6: China – Midyear Population, by Age and Sex, 2007 and 2012
Figure 4-3: China – Midyear Population, by Age, 2007 and 2012
Table 4-7: China Fertility Rates and Births (Estimated 2005, 2007; Projected 2008, 2025)
Figure 4-4: China Fertility Rates and Births (Estimated 2005, 2007; Projected 2008, 2025)
Table 4-8: China Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
Figure 4-5: China Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025
Table 4-9: China Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
Figure 4-6: China Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
Table 4-10: China Leading Causes of Death, Estimated 2007
Figure 4-7: China Leading Causes of Death, Estimated 2007
Table 4-11: HIV Indicators, China
Figure 4-8: HIV Indicators, China
Table 4-12: Tuberculosis Surveillance and Epidemiology, China
Figure 4-9: Tuberculosis Surveillance and Epidemiology, China
Table 4-13: China Malaria Data, 1990-2003
Figure 4-10: China Malaria Data, 1990-2003
Table 4-14: Cancer Surveillance and Epidemiology, China
Table 4-15: Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007
Figure 4-11: Estimated Cancer Incidence in China by Most Common Types of Cancer, Compared to World, 2007
Table 4-16: China Pharmaceutical Market Analysis, 2005-2007
Table 4-17: Forecasted China Pharmaceutical Market Analysis: 2008-2012
Figure 4-12: China Pharmaceutical Market Analysis: 2005-2012
Table 4-18: China Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
Figure 4-13: China Pharmaceutical Market Analysis by Product Segment, 2007
Figure 4-14: China Pharmaceutical Market Forecast by Product Segment, 2012
Table 4-19: Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007
Figure 4-15: Estimated Sales of Pharmaceuticals in China by Local and Foreign Suppliers, 2007

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN RUSSIA
Table 5-1: Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Figure 5-1: Russia Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Table 5-2: Russia’s Economic Profile
Table 5-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
Table 5-4: Healthcare Professionals in Russia by Type, Estimated 2004 and 2007
Figure 5-2: Healthcare Professionals in Russia by Type, Estimated 2004 and 2007
Table 5-5: Russia – Midyear Population, by Age and Sex, 2007 and 2012
Figure 5-3: Russia – Midyear Population, by Age 2007 and 2012
Table 5-6: Russia Fertility Rates and Births (Estimated 2005, 2007; Projected 2008, 2025)
Figure 5-4: Russia Fertility Rates and Births (Estimated 2005, 2007; Projected 2008- 2025)
Table 5-7: Russia Life Expectancy at Birth, 2005, 2006, 2007; (Projections, 2008 through 2012, and 2025)
Figure 5-5: Russia Life Expectancy at Birth by Sex, 2005; Projections 2010 and 2025
Table 5-8: Russia Mortality Rates and Numbers (Estimated 2005, 2007; Projected 2008, 2025)
Figure 5-6: Russia Mortality Rates and Numbers Estimated 2005, 2007; Projected 2008, 2025
Table 5-9: Russia Leading Causes of Death, Estimated 2007
Figure 5-7: Russia Leading Causes of Death, Estimated 2007
Table 5-10: HIV Indicators, Russia
Figure 5-8: HIV Indicators, Russia
Table 5-11: Tuberculosis Surveillance and Epidemiology, Russia
Figure 5-9: Tuberculosis Surveillance and Epidemiology, Russia
Table 5-12: Cancer Surveillance and Epidemiology, Russia
Table 5-13: Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007
Figure 5-10: Estimated Cancer Incidence in Russia by Most Common Types of Cancer, Compared to World, 2007
Table 5-14: Russia Pharmaceutical Market Analysis, 2005-2007
Table 5-15: Forecasted Russia Pharmaceutical Market Analysis: 2008-2012
Figure 5-11: Russia Pharmaceutical Market Analysis: 2005-2012
Table 5-16: Russia Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
Figure 5-12: Russia Pharmaceutical Market Analysis by Product Segment, 2007
Figure 5-13: Russia Pharmaceutical Market Forecast by Product Segment, 2012
Table 5-17: Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007
Figure 5-14: Estimated Sales of Pharmaceuticals in Russia by Local and Foreign Suppliers, 2007

CHAPTER SIX: PHARMACEUTICAL MARKETS IN BRAZIL
Table 6-1: Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Figure 6-1: Brazil Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Table 6-2: Brazil’s Economic Profile
Table 6-3: Gross National Income Per Capita and Growth Comparison for 2005 and 2006
Table 6-4: Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007
Figure 6-2: Healthcare Professionals in Brazil by Type, Estimated 2004 and 2007
Table 6-5: Brazil – Midyear Population, by Age and Sex, 2007 and 2012
Figure 5-3: Brazil – Midyear Population, by Age and Sex, 2007 and 2012
Table 6-6: Brazil Fertility Rates and Births
Figure 6-4: Brazil Fertility Rates and Births
Table 6-7: Brazil Life Expectancy at Birth, 2000, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
Figure 6-5: Brazil Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2025
Table 6-8: Brazil Mortality Rates and Numbers
Figure 6-6: Brazil Mortality Rates and Numbers
Table 6-9: Brazil Leading Causes of Death, Estimated 2007
Figure 6-7: Brazil Leading Causes of Death, Estimated 2007
Table 6-10: Tuberculosis Surveillance and Epidemiology, Brazil
Figure 6-8: Tuberculosis Surveillance and Epidemiology, Brazil
Table 6-11: HIV Indicators, Brazil
Figure 6-9: HIV Indicators, Brazil
Table 6-12: Brazil Malaria Data, 1990-2003
Figure 6-10: Brazil Malaria Data, 1990-2003
Table 6-13: Cancer Surveillance and Epidemiology, Brazil
Table 6-14: Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World
Figure 6-11: Estimated Cancer Incidence in Brazil by Most Common Types of Cancer, Compared to World, 2007
Table 6-15: Brazil Pharmaceutical Market Analysis, 2005-2007
Table 6-16: Forecasted Brazil Pharmaceutical Market Analysis: 2008-2012
Figure 6-12: Brazil Pharmaceutical Market Analysis: 2005-2012
Table 6-17: Brazil Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
Figure 6-13: Brazil Pharmaceutical Market Analysis by Product Segment, 2007
Figure 6-14: Brazil Pharmaceutical Market Forecast by Product Segment, 2012
Table 6-18: Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007
Figure 6-15: Estimated Sales of Pharmaceuticals in Brazil by Local and Foreign Suppliers, 2007

CHAPTER SEVEN: MARKET SUMMARY
Table 7-1: BRIC Market Analysis, 2005-2007
Table 7-2: Forecasted BRIC Market Analysis: 2008-2012
Figure 7-1: BRIC Market Analysis: 2005-2012
Table 7-3: World Pharmaceutical Markets by Country/Region, 2007
Figure 7-2: World Pharmaceutical Markets by Country/Region, 2007